Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Chien

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatmentRejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)|May 23, 2025
Unlocking Asthma Remission: Key Insights From an Expert Roundtable DiscussionDennis Thomas, Hayley Lewthwaite, Peter G Gibson, et al.
The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe AsthmaTesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal HypersensitivityAnne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Allergology International : Official Journal of the Japanese Society of Allergology|July 1, 2026
Sustained clinical remission and relapse of severe eosinophilic asthma following long-term mepolizumab treatmentRejoy Sabin Thomas, Dennis Thomas, Vanessa M McDonald, et al.
Respirology (Carlton, Vic.)|May 23, 2025
Unlocking Asthma Remission: Key Insights From an Expert Roundtable DiscussionDennis Thomas, Hayley Lewthwaite, Peter G Gibson, et al.
The European Respiratory Journal|March 7, 2020
Mepolizumab effectiveness and identification of super-responders in severe asthmaErin S Harvey, David Langton, Constance Katelaris, et al.
Respiratory Medicine|September 5, 2025
Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab RegistryErin S Harvey, Yuto Hamada, Sarah A Hiles, et al.
International Journal of Environmental Research and Public Health|June 24, 2022
'Breathing Fire': Impact of Prolonged Bushfire Smoke Exposure in People with Severe AsthmaTesfalidet Beyene, Erin S Harvey, Joseph Van Buskirk, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 17, 2023
Impact of Landscape Fire Smoke Exposure on Patients With Asthma With or Without Laryngeal HypersensitivityAnne E Vertigan, Erin S Harvey, Tesfalidet Beyene, et al.
Allergy|August 26, 2023
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patientsDennis Thomas, Vanessa M McDonald, Sean Stevens, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 5, 2021
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab RegistryDennis Thomas, Erin S Harvey, Vanessa M McDonald, et al.
Pageof 2